Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
23.05
-0.07 (-0.30%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 75 | 4 | - | - | - | - |
| Enterprise Value | 64 | 5 | - | - | - | - |
| Last Close Price | 23.05 | 6.41 | - | - | - | - |
| PB Ratio | 1.22 | -1.42 | - | - | - | - |
| Debt / Equity Ratio | 0.06 | -0.80 | -0.20 | -0.15 | -0.30 | -0.07 |
| Net Debt / Equity Ratio | -0.18 | -0.62 | -0.18 | -0.13 | -0.30 | -0.07 |
| Net Debt / EBITDA Ratio | - | - | - | -0.30 | - | - |
| Quick Ratio | 0.90 | 0.13 | 0.02 | 0.02 | - | - |
| Current Ratio | 2.01 | 0.34 | 0.02 | 0.02 | - | 0.02 |
| Return on Assets (ROA) | -20.64% | -645.79% | -5663.30% | - | - | - |
| Return on Capital Employed (ROCE) | -20.90% | 279.00% | 106.50% | 62.50% | 32.50% | 37.80% |
| Earnings Yield | -31.62% | -205.89% | - | - | - | - |
| Buyback Yield / Dilution | -170.72% | -336.69% | -193.25% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.